Noticias y vídeos - KALI INC. KALY - Página 2

DALLAS, Nov. 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a second party has approached the company to express interest in acquiring KALY’s U.S. Patented Cannabis Extraction Process and related biopharmaceutical technology has valued the technology at $50 million. KALY recently announced entering into discussions with a first investor to explore a possible sale of KALY’s cannabis...

DALLAS, Nov. 06, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced that the company’s CBD extraction offering is beginning to see a second wave of contract opportunities. KALY has so far announced three CBD extraction agreements with hemp farming operations worth a potential $15 million. Under the agreements, KALY consigns the crop and harvests the hemp in addition to executing the comprehensive CBD...

DALLAS, Nov. 05, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced plans to introduce USDA Organic CBD Oil and USDA Organic CBD infused beverages early next year in 2020. KALY recently announced a USDA Organic Certification for its first harvested hemp crop. Using KALY’s U.S. Patented Cannabis Extraction Process, KALY is now processing CBD oil from the USDA Organic Certified hemp crop. With the CBD...

DALLAS, Nov. 01, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed an investor interested in acquiring KALY’s U.S. Patented Cannabis Extraction Process and related biopharmaceutical technology has valued the technology at $50 million. Yesterday KALY announced taking a next step with the investor to explore a possible sale. KALY management has asked the investor to provide a “working” term-sheet...

DALLAS, Oct. 31, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced taking a next step with the investor that has recently valued KALY’s biopharmaceutical technology at $50 Million. The valuation has been presented to KALY by an investor interested in acquiring KALY’s U.S. Patented Cannabis Extraction Process and associated biopharmaceutical research and developments. KALY management has asked the...

DALLAS, Oct. 30, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a new CBD extraction agreement adding to the company’s previously announced extraction contracts with hemp farming operations worth a potential total of $15 million. This is a third consignment agreement whereby the hemp farming operation consigns its crop to KALY for harvesting and extraction and KALY, after processing the harvested...

DALLAS, Oct. 30, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a USDA Organic Certification for its first crop hemp crop. KALY has a U.S. Patent for Cannabis Extraction and provides hemp cultivators with harvesting and extraction services. KALY has signed harvesting and extraction contracts so far worth approximately $15 million. The first hemp harvest and extraction contract now under way in the...

DALLAS, Oct. 30, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a $50 Million valuation for its cannabis extract biopharmaceutical technology. The valuation has been presented to KALY by an investor interested in acquiring KALY’s U.S. Patented Cannabis Extraction Process and associated biopharmaceutical research and developments. KALY management has entered discussions with the investor but not...

DALLAS, Oct. 28, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced plans to issue an update this Wednesday, October 30 th , 2019 regarding the recent acquisition interest in KALY’s Cannabis Extract Biopharmaceutical Technology. KALY CEO Frederick Ferri commented on the acquisition interest in KALY’s Cannabis Extract Biopharmaceutical Technology indicating that the interest stems from industry...

DALLAS, Oct. 25, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced CEO Frederick Ferri met with Butterball’s Jim Maxwell and North Carolina 7 th District Congressman David Rouzer to discuss the expansion of the hemp industry in North Carolina. Utilizing KALY’s U.S. Patented Cannabis Extraction Process, KALY has signed direct cannabis extraction contracts with hemp farming operations with a total...

DALLAS, Oct. 24, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed a recent conditional acquisition proposal from an investor interested in the acquisition of KALY’s Cannabis Extract Biopharmaceutical Technology. KALY CEO Frederick Ferri commented yesterday on the acquisition interest in KALY’s Cannabis Extract Biopharmaceutical Technology indicating that the interest stems from industry investors...

DALLAS, Oct. 23, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced its new CBD Hemp4mula Gummies are now available to order on www.usmj.com . www.usmj.com/Hemp4mula-Gummies Hemp4mula Gum is also available from USMJ’s eCommerce site at www.usmj.com/Hemp4mula-gum . In the fourth quarter of last year, 2018, KALY acquired NCMB. NCMB owns and operates a US Patented Cannabis Extraction Process. In NCMB’s...

DALLAS, Oct. 23, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced the company has recently received serious interest from an investor exploring the acquisition of KALY’s Cannabis Extract Biopharmaceutical Technology. KALY CEO Frederick Ferri commented on the acquisition interest in KALY’s Cannabis Extract Biopharmaceutical Technology indicating that the interest stems from industry investors...

DALLAS, Oct. 17, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today published photos on the company’s website from its first historic hemp harvest since the Federal legalization of hemp cultivation in the United States. KALY has already begun harvesting its first hemp crop in the state of New York signed under a consignment contract worth a potential $5 million. KALY has hired a photo journalist to record the...

DALLAS, Oct. 15, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced recent interest from Canadian cannabis sector businesses in reaction to Cannabis 2.0. Later this week, on October 17, 2019, cannabis infused edibles, beverages, extracts and topicals become legal for sale in Canada. KALY owns and operates a U.S. Patented Cannabis Extraction Process used currently for the production of beverages and...

DALLAS, Oct. 14, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced engaging a photo journalist to record the company’s first historic hemp harvest since the Federal legalization of hemp cultivation in the United States. KALY has already begun harvesting its first hemp crop in the state of New York signed under a consignment contract worth a potential $5 million. The first photos taken by the photo...

DALLAS, Oct. 11, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced today announced that as part of the sole license it has granted to Puration, Inc. (USOTC: PURA) for use of the KALY U.S. Patented Cannabis Extraction Process for the production of beverages, KALY has recently been engaged by PURA to design a coffee infusion process. Earlier today, PURA announced the company will begin producing CBD...

DALLAS, Oct. 10, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced what it referred to as “exploding” demand for its CBD extraction services. KALY has already begun harvesting its first hemp crop in the state of New York signed under a consignment contract worth a potential $5 million. Word is out on KALY’s process and KALY is receiving what it characterizes as “non-stop” calls for extraction...

DALLAS, Oct. 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed the company is pursuing the development of Over-The-Counter (OTC) and prescription CBD treatments. The company yesterday released an update on its latest Cannabis Extract Biopharmaceutical developments. The information from yesterday’s release to include the specifics on the OTC and prescription CBD treatments is contained here in...

DALLAS, Oct. 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced an anticipated jump in revenue in Q4 2019 related to the company’s CBD extraction contracts with hemp farming operations currently underway now that the hemp harvest season is in full swing. The company has announced hemp extraction contracts worth a potential $15 million in revenue. While not all that revenue will be realized in one...